Polystyrene sulfonate
Find information on thousands of medical conditions and prescription drugs.

Kayexalate

Sodium polystyrene sulfonate is a type of polymer and ionomer based on polystyrene. It may be prepared by polymerization or copolymerization of sodium styrene sulfonate or by sulfonation of polystyrene. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
Clonazepam
K-Dur
Kadian
Kainic acid
Kanamycin
Kantrex
Kariva
Kayexalate
Keflex
Kefzol
Kemstro
Keppra
Ketalar
Ketamine
Ketanserin
Ketek
Ketoconazole
Ketoprofen
Ketorolac
Ketotifen
Kionex
Klor-con
Klotrix
Konazol
Korostatin
Kytril
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Use in medicine

Sodium polystyrene sulfonate (Kayexalate®, Kionex®) is a medication used to treat high potassium levels. It is taken orally or by rectum, as an enema, and functions as a potassium-binding resin in the intestines. Side effects can include electrolyte disturbances such as low potassium levels, low calcium levels, and sodium retention. Intestinal disturbances are also common, including constipation, nausea and vomiting, and lack of appetite.

Read more at Wikipedia.org


[List your site here Free!]


Hyperkalemia
From Gale Encyclopedia of Medicine, 4/6/01 by Tom Brody

Definition

The normal concentration of potassium in the serum is in the range of 3.5 to 5.0 mM. Hyperkalemia refers to serum or plasma levels of potassium ions above 5.0 mM. The concentration of potassium is often expressed in units of milliequivalents per liter (mEq/L), rather than in units of millimolarity (mM). Both units mean the same thing when applied to concentrations of potassium ions.

Description

A normal adult who weighs about 70 kg contains a total of about 3.6 moles of potassium ions in the body. Most of this potassium (about 98%) occurs inside various cells and organs, where its concentration is about 150 mM. This level is in contrast to the much lower concentration found in the blood serum, where only about 0.4% of the body's potassium resides. Hyperkalemia can be caused by an overall excess of body potassium, or by a shift from inside to outside cells. For example, hyperkalemia can be caused by the sudden release of potassium ions from muscle into the surrounding fluids.

In a normal person, hyperkalemia from too much potassium in the diet is prevented by at least three types of regulatory processes. First, various cells and organs act to prevent hyperkalemia by taking up potassium from the blood. It is also prevented by the action of the kidneys, which excrete potassium into the urine. A third protective mechanism is vomiting. Consumption of a large dose of potassium ions, such as potassium chloride, induces a vomiting reflex to expel most of the potassium before it can be absorbed.

Causes & symptoms

Hyperkalemia can occur from a variety of causes, including the consumption of too much of a potassium salt; the failure of the kidneys to normally excrete potassium ions into the urine; the leakage of potassium from cells and tissues into the bloodstream; and from acidosis. The most common cause of hyperkalemia is kidney (or renal) disease, which accounts for about three quarters of all cases. Kidney function is measured by the glomerular filtration rate, the rate at which each kidney performs its continual processing and cleansing of blood. The normal glomerular filtration rate is about 100 ml/min. If the kidney is damaged so that the glomerular filtration rate is only 5 ml/min or less, hyperkalemia may result, especially if high-potassium foods are consumed. The elderly are at particular risk, since many regulatory functions of the body do not work well in this population. Elderly patients who are being treated with certain drugs for high blood pressure, such as spironolactone (Aldactone) and triamterene (Dyazide), must especially be monitored for possible hyperkalemia, as these medications promote the retention of potassium by the kidneys.

Hyperkalemia can also be caused by a disease of the adrenal gland called Addison's disease. The adrenal gland produces the hormone aldosterone that promotes the excretion of potassium into the urine by the kidney.

Hyperkalemia can also result from injury to muscle or other tissues. Since most of the potassium in the body is contained in muscle, a severe trauma that crushes muscle cells results in an immediate increase in the concentration of potassium in the blood. Hyperkalemia may also result from severe burns or infections.

Acidic blood plasma, or acidosis, is an occasional cause of hyperkalemia. Acidosis, which occurs in a number of diseases, is defined as an increase in the concentration of hydrogen ions in the bloodstream. In the body's attempt to correct the situation, hydrogen is taken up by muscle cells out of the blood in an exchange mechanism involving the transfer of potassium ions into the bloodstream. This can abnormally elevate the plasma's concentration of potassium ions. When acidosis is the cause of hyperkalemia, treating the patient for acidosis has two benefits: a reversal of both the acidosis and the hyperkalemia.

Symptoms of hyperkalemia include abnormalities in the behavior of the heart. Heart abnormalities of mild hyperkalemia (5.0 to 6.5 mM potassium) can be detected by an electrocardiogram (ECG or EKG). With severe hyperkalemia (over 8.0 mM potassium), the heart may beat at a dangerously rapid rate (fibrillation) or stop beating entirely (cardiac arrest). Patients with moderate or severe hyperkalemia may also develop nervous symptoms such as tingling of the skin, numbness of the hands or feet, weakness, or a flaccid paralysis, which is characteristic of both hyperkalemia and hypokalemia (low plasma potassium).

Diagnosis

Hyperkalemia can be measured by acquiring a sample of blood, preparing blood serum, and using a potassium sensitive electrode for measuring the concentration of potassium ions. Alternatively, atomic absorption spectroscopy can be used for measuring potassium. Since high or low potassium levels result in abnormalities in heart function, the electrocardiogram is usually the method of choice for the diagnosis of both hyperkalemia and hypokalemia.

Treatment

Insulin injections are used to treat hyperkalemia in emergency situations. Insulin is a hormone well known for its ability to stimulate the entry of sugar (glucose) into cells. It also provokes the uptake of potassium ions by cells, decreasing potassium ion concentration in the blood. When insulin is used to treat hyperkalemia, glucose is also injected. Serum potassium levels begin to decline within 30 to 60 minutes and remain low for several hours. In non-emergency situations, hyperkalemia can be treated with a low potassium diet. If this does not succeed, the patient can be given a special resin to bind potassium ions. One such resin, sodium polystyrene sulfonate (Kayexalate), remains in the intestines, where it absorbs potassium and forms a complex of resin and potassium. Eventually this complex is excreted in the feces. A typical dose of resin is 15 grams, taken one to four times per day. The correction of hyperkalemia with resin treatment takes at least 24 hours.

Prognosis

The prognosis for specifically correcting hyperkalemia is excellent. However, hyperkalemia is usually caused by kidney failure, an often irreversible and eventually fatal condition.

Prevention

Healthy people are not at risk for hyperkalemia. Patients with renal disease and those on certain diuretic medications must be monitored to prevent its occurrence.

Key Terms

Acidosis
An abnormally high acid (hydrogen ion) concentration in blood plasma. The unit of acid content is pH, with a lower value indicating more acidic conditions. Blood plasma normally has a pH of 7.35-7.45. Alkaline blood has a pH value greater than pH 7.45. When the blood pH value is less than 7.35, the patient is in acidosis.

Further Reading

For Your Information

    Books

  • The American Dietetic Association. Handbook of Clinical Dietetics. New Haven, CT: Yale Univ. Press, 1992.
  • Brody, Tom. Nutritional Biochemistry. San Diego, CA: Academic Press, 1998.
  • Levinsky, N.G. "Fluids and Electrolytes." In Harrison's Principles of Internal Medicine, edited by K.J. Isselbacher, et al. Engelwood Cliffs, New Jersey: Prentice-Hall, 1995.
  • Zeman, F. and D.M. Dey. Applications in Medical Nutrition Therapy, 2nd edition. Engelwood Cliffs, New Jersey: Prentice-Hall, 1995.

    Periodicals

  • Greenberg, A. "Hyperkalemia: treatment options." Seminars in Nephrology 18 (1998): 46-57.

Gale Encyclopedia of Medicine. Gale Research, 1999.

Return to Kayexalate
Home Contact Resources Exchange Links ebay